CVS Health (NYSE:CVS) Issues FY 2026 Earnings Guidance

CVS Health (NYSE:CVS) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 5.940-6.140 for the period, compared to the consensus EPS estimate of 7.160. The company issued revenue guidance of -.

Analyst Ratings Changes

A number of research firms have recently weighed in on CVS. Truist Financial set a $100.00 price objective on CVS Health in a research note on Wednesday, December 10th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Leerink Partners raised their target price on CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.82.

CVS Health Stock Performance

CVS Health stock opened at $76.06 on Tuesday. CVS Health has a fifty-two week low of $53.36 and a fifty-two week high of $85.15. The stock’s 50 day simple moving average is $78.56 and its two-hundred day simple moving average is $75.87. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The stock has a market cap of $96.55 billion, a price-to-earnings ratio of 200.16, a PEG ratio of 0.72 and a beta of 0.50.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $0.99 by $0.10. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts expect that CVS Health will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is currently 700.00%.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Q4 beat: CVS reported adjusted EPS of $1.09 (vs. $0.99 expected) and revenue of $105.69B (above estimates), showing stronger sales and prescription volume that helped beat Street forecasts. Press Release
• Positive Sentiment: Turnaround traction: Management says the turnaround is taking hold — revenue rose ~8% in Q4 and operational changes at Pharmacy/Aetna are improving approvals and flow, which supports margin recovery and longer‑term profit potential. CVS Health’s turnaround is paying off
• Neutral Sentiment: Operational metrics: CVS reported record FY revenue (~$402.1B) and generated $10.6B in operating cash flow and completed a shift to cost‑based reimbursement — positive fundamentals but not an immediate catalyst. PR Newswire: Q4 and FY results
• Negative Sentiment: Guidance miss: CVS set FY‑2026 EPS guidance at $5.94–$6.14, materially below the consensus (~$7.16), which is the primary reason for the stock weakness despite the quarter’s beats.
• Negative Sentiment: Medicare/rate risk: Analysts and coverage pieces highlight ongoing concerns about Medicare reimbursement proposals and rate pressure for the insurance business, which could weigh on margins and investor sentiment. CVS Stock Falls After Earnings Beat
• Negative Sentiment: Regulatory/market sensitivity: Commentary ahead of the print flagged Medicare proposals as a risk; any further clarity that reduces reimbursement or increases uncertainty could prolong the stock’s underperformance. MSN: Under Pressure From Medicare Proposal

Hedge Funds Weigh In On CVS Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Sei Investments Co. increased its stake in shares of CVS Health by 17.4% in the 2nd quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock worth $62,474,000 after purchasing an additional 134,535 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in CVS Health by 1.2% in the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator’s stock worth $77,353,000 after buying an additional 13,329 shares in the last quarter. Treasurer of the State of North Carolina raised its stake in shares of CVS Health by 1.3% in the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator’s stock worth $40,358,000 after buying an additional 7,588 shares during the period. HUB Investment Partners LLC lifted its position in shares of CVS Health by 25.0% during the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator’s stock valued at $1,039,000 after buying an additional 3,011 shares in the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of CVS Health by 8.0% during the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator’s stock valued at $111,017,000 after acquiring an additional 119,439 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.